期刊文献+

The Vienna Cancer Stem Cell Club (VCSCC): First 10 Years and Future Perspectives

The Vienna Cancer Stem Cell Club (VCSCC): First 10 Years and Future Perspectives
下载PDF
导出
摘要 In 2002, the Vienna Cancer Stem Cell Club (VCSCC) was inaugurated by a group of scientists at the Medical University of Vienna, with the primary goal to initiate and promote cancer stem cell (CSC) research in Austria and to exploit knowledge from this new discipline in translational approaches, During the first years following inauguration, the VCSCC-community was small and left without major funding. However, over time the consortium was able to launch several major project-lines, supported in part by the National Science Funds, a Genome Program, and the Ludwig-Boltzmann Society. Today, the VCSCC provides a robust intellectual platform for ongoing research in the field of translational oncology and CSC-research in Austria. In addition, the VCSCC is connected to several major CSC-networks and centers in Europe and in North America, and is a well-recognized group in the field. The VCSCC also organized a series of CSC Meetings and Conferences, and contributed essentially to a recently published classification of CSC. There is also hope that the VCSCC-consortium will further advance the field of CSC research in the future, and will create novel concepts, with the ultimate aim to improve anti-cancer therapy through elimination, suppression, or long-term control of cancer-initiating cells.
出处 《Journal of Life Sciences》 2013年第6期577-585,共9页 生命科学(英文版)
关键词 Stem cells cancer stem cells molecular targets targeted drug therapies curative anti-cancer approaches. Stem cells cancer stem cells molecular targets targeted drug therapies curative anti-cancer approaches.
  • 相关文献

参考文献58

  • 1T. Reya, S.J. Morrison, M.F. Clarke, I.L. Weissman, Stem cells, cancer, and cancer stem cells, Nature 414 (2001) 105-111.
  • 2R. Pardal, M.F. Clarke, S.J. Morrison, Applying the principles of stem-cell biology to cancer, Nat Rev Cancer 3 (2003) 895-902.
  • 3K. Polyak, W.C. Hahn, Roots and stems: Stem cells in cancer, Nat Med 12 (2006) 296-300.
  • 4M.L. Guzman, C.T. Jordan, Considerations for targeting malignant stem cells in leukemia, Cancer Control 11 (2004) 97-104.
  • 5W.R. Sperr, A.W. Hauswirth, S. Florian, L. Ohler, K. Geissler, P. Valent, Human leukaemic stem cells: A novel target oftherapy, Eur J Clin Invest 34 (S2) (2004) 31-40.
  • 6M. AI-Hai, M.S. Wicha, A. Benito-Hernandez, S.1. Morrison, M.F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proc Nat! Acad Sci (USA) 100 (2003) 3983-3988.
  • 7A. Schulenburg, H. Ulrich-Pur, D. Thurnher, B. Erovic, S. Florian, W.R. Sperr, et aI., Neoplastic stem cells: A novel therapeutic target in clinical oncology, Cancer 107 (2006) 2512-2520.
  • 8T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, et al., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature 367 (1994) 645-648.
  • 9D. Bonnet, 1.E. Dick, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat Med 3 (1997) 730-737.
  • 10K.J. Hope, L. Jin, 1.E. Dick, Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity, Nat Immunol 5 (2004) 738-743.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部